By Giles Clasen In Uganda, where more than 1.4 million individuals live with HIV, access to life-saving antiretroviral (ARV) ...

Health Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in foreign ...

The Trump administration's decision to pause U.S. foreign aid has significantly disrupted the supply of HIV treatments in eight countries. Six of the eight affected countries are in Africa. ・WHO warns ...

As the nation celebrates Social Work Day on Tuesday (March 18), the Department of Social Welfare and Development (DSWD), which is home to the country’s social workers, takes into center stage the stor ...

Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...

Despite government reassurances, health experts have serious concerns about the long-term implications of the withdrawal of funding for HIV/Aids treatment programmes.

Artemis Resources Limited (LON:ARV – Get Free Report)’s share price dropped 6.2% during trading on Tuesday . The company traded as low as GBX 0.40 ($0.01) and last traded at GBX 0.41 ($0.01).

Since its approval in 2013, DTG has emerged as a more effective and cost-efficient alternative to older ARV regimens.

Arvinas/Pfizer's vepdegestrant shows efficacy in mutated breast cancer patients but not in broader population, failing to ...

A groundbreaking SAMRC study has uncovered significant underreporting of HIV-related deaths in South Africa, despite the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics ...